MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, is pleased to announce the addition of two accomplished professionals to its leadership team. Marci Allison joins ...

New statistics reveal that breast and cervical cancers are now the leading causes of death among South African women, ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

Dr Nwokwu further said that, in collaboration with the World Health Organisation (WHO), the Federal Ministry of Health has developed awareness materials on childhood cancer. These materials will be ...

Over the years, cancer incidence has been steadily increasing in the country because of several factors like lifestyle ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

CNW/ - This World Cancer Day, Pfizer Canada ULC, together with Rethink Breast Cancer, Colorectal Cancer Canada, Lung Health Foundation, Lung Cancer Canada, and the Quebec Lung Association, is pleased ...